Respiratory Disease

Empowering Labs with Targeted and Syndromic Testing

Respiratory Disease Portfolio


For respiratory infection testing, clinical labs must adapt quickly to changing needs based on seasonal demand, as well as patient age and overall health. With significant overlap of symptoms across infections and an evolving reimbursement landscape, labs must have flexibility in assays to deliver high-quality, cost-effective results.


Whether you need high-volume influenza assays or a broad selection of targets, we can help.


Luminex offers the most scalable, flexible respiratory disease testing portfolio to assist labs with managing the needs of physicians, patients, and the overall healthcare system. Our molecular diagnostic assays allow you to adjust target selection and sample throughput for maximum testing accuracy, cost efficiency, and clinical impact.


Learn more about our respiratory disease testing options:

Read more

Leave A Comment

Your email address will not be published. Required fields are marked *